| Coronary Artery Bypass Surgery | coronary artery disease, in all type of patients | vs CABG | - | - | - | - | - | | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
|---|
| All cause death | no data | | Long term death | no data | | cardiac event (fatal and non fatal ) | no data | | Angina class improvement + death | no data | | Angina relief | no data |
TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients | Trial | Studied treatment | Control | Patients |
|---|
| Allen, 2000 | coronary bypass of suitable vessels plus transmyocardial revascularization to areas not graftable | coronary bypass alone with nongraftable areas left unrevascularized | patients whose standard of care was coronary artery bypass grafting and who had one or more ischemic areas not amenable to bypass grafting | | Loubani, 2003 | coronary artery bypass grafting plus transmyocardial laser revascularization with a holmium:YAG (yttrium-aluminum-garnet) laser to nongraftable areas | coronary artery bypass grafting | Patients who had elective coronary artery bypass with one or more nongraftable coronary arteries | | Zhao, 2006 | transmyocardial laser revascularization (holmium: YAG) combined with off-pump coronary artery bypass | off-pump coronary artery bypass | patients with diffusely diseased target vessels |
|
